1Division of Infectious Diseases,Department of Medicine,Medical College of Wisconsin,Milwaukee,Wisconsin.
2Infection Prevention and Control Department,Froedtert Memorial Lutheran Hospital,Milwaukee,Wisconsin.
Infect Control Hosp Epidemiol. 2018 Dec;39(12):1484-1486. doi: 10.1017/ice.2018.241. Epub 2018 Oct 23.
In 2018, the Clostridium difficile LabID event methodology changed so that hospitals doing 2-step tests, nucleic acid amplification test (NAAT) plus enzyme immunofluorescence assay (EIA), had their adjustment modified to EIA-based tests, and only positive final tests (eg, EIA) were counted in the numerator. We report the immediate impact of this methodological change at 3 Milwaukee hospitals.
2018 年,艰难梭菌检测方法发生了变化,对于进行两步检测的医院(核酸扩增检测[NAAT]加酶免疫荧光检测[EIA]),调整方法改为基于 EIA 的检测,只有最终阳性检测(如 EIA)才被计入分子。我们报告了在密尔沃基的 3 家医院中这一方法改变的即时影响。